2016, Number 3
<< Back Next >>
Rev Cub de Reu 2016; 18 (3)
Uveitis. A challenge for the rheumatologist
Luaces MÁ, Ortega SM, Nápoles AA, Reyes PY, Prada HDM
Language: Spanish
References: 12
Page: 275-280
PDF size: 108.86 Kb.
ABSTRACT
The uveitis is a heterogeneous group of clinical entities, from very different causes, which have in common the intraocular inflammation. They can be the manifestation of disease widespread as established, be a process limited to the eyeball, or even be the first clinical sign of an entity that will develop over time. Therefore, rheumatologist, with the help of an eye examination, will attempt to search specific extraocular manifestations, for appropriate complementary tests according to their diagnostic hypothesis.
REFERENCES
Rosenbaum JT. An algorithm for the systemic evaluation of patients with uveítis: Guidelines for the consultant. Semin Arthritis Rheum. 1990;19:248-57.
Bañares A, Benitez del Castillo JM. Elección de pruebas diagnósticas en uveítis. Racionalidad médica y diagnóstica. St Ophthalmol. 1995;14:23-32.
Benítez del Castillo JM, Bañares A, Hernández C, Pastrana P, García FJ, Fernández B, Jover JA, García J. Modelo inteligente para acceder al diagnóstico en el paciente con uveítis. Arch Soc Esp Oftalmol. 1995;69:487-96.
Hernández C, Bañares A. Uveítis y enfermedades reumatológicas. Rev Esp Reum. 1995;22:83-8.
Gegúndez JA. Aproximación clínica al diagnóstico de las uveítis. Madrid: Ed. Sociedad Española de Oftalmología; 2002.
Nussemblatt RB, Whitcup SM, Palestine AG. Uveitis: Fundamentals and clinical practice. 2nd edition. Chicago: Ed. Mosby Year Book; 1996.
Smith RE, Nozik RA. Uveitis: a clinical approach to diagnosis and management. 2nd. Ed. Baltimore: Ed. Williams & Wilkins; 1989.
Voeldvari I, Wierk A. Methtotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Reumatol. 2005;32:362-5.
Levy-Clarke GA, Nussenblantt RB, Smith Janine A. Management if chronic pediatric uveitis.Curent Opinion in Ophtalmology. 2005;16(5):281-8.
Braun J, Baraliakos X, Listing J, Sieper J .Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005 Aug;52(8):2447-51.
Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M, Dougados M. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis. 2006 Dec;65(12):1631-4.
Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gul A. .Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial. Arthritis Rheum. 2005 Aug;52(8):2478-84.
Full text